WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001081385) A NOVEL POLYPEPTIDE, A HUMAN REDUCTASE NUCLEOTIDE 9 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/081385    International Application No.:    PCT/CN2001/000591
Publication Date: 01.11.2001 International Filing Date: 23.04.2001
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01), C12N 9/02 (2006.01)
Applicants: BIOWINDOW GENE DEVELOPMENT INC. SHANGHAI [CN/CN]; 12F, 3rd Building 1111 Zhongshan Bei Er Road Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: WATSON & BAND LAW OFFICES; 61 Nanjing Road (E) 11th Floor Shanghai 200002 (CN)
Priority Data:
00 1 15483.4 27.04.2000 CN
Title (EN) A NOVEL POLYPEPTIDE, A HUMAN REDUCTASE NUCLEOTIDE 9 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
(FR) NOUVEAU POLYPEPTIDE, NUCLEOTIDE REDUCTASE HUMAINE 9, ET POLYNUCLEOTIDE CODANT POUR CE POLYPEPTIDE
Abstract: front page image
(EN)The present invention discloses a novel polypeptide, a human reductase nucleotide 9, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as purine and pyrimidine metabolism anomalies, various tumours, embryonic and growth disorders. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the human reductase nucleotide 9.
(FR)L'invention concerne un nouveau polypeptide, une nucléotide réductase humaine 9, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des anomalies du métabolisme de la purine et de la pyrimidine, de toutes sortes de tumeurs, des troubles du développement de l'embryon et des troubles du développement et de la croissance. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la nucléotide réductase humaine 9.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)